Search research articles
Contact Us
Filters
Showing results (61-70 of 111) with videos related to
Page
of 12
Sort By:
Circulation
|
April 1, 1995
Body surface potential distributions during idiopathic ventricular tachycardia
D Klug, A Ferracci, F Molin, et al.
Neurosurgery
|
July 11, 2013
Intertumoral and intratumoral heterogeneity as a barrier for effective treatment of medulloblastoma
Xin Wang, Vijay Ramaswamy, Marc Remke, et al.
Circulation
|
September 1, 1991
Epicardial and endocardial mapping of ventricular tachycardia in patients with myocardial infarction. Is the origin of the tachycardia always subendocardially localized?
W Kaltenbrunner, R Cardinal, M Dubuc, et al.
Acta Neuropathologica Communications
|
January 28, 2014
Polycomb group gene BMI1 controls invasion of medulloblastoma cells and inhibits BMP-regulated cell adhesion
Ashirwad Merve, Adrian M Dubuc, Xinyu Zhang, et al.
Circulation
|
January 11, 2000
Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia
A C Skanes, M Dubuc, G J Klein, et al.
European Heart Journal
|
July 3, 2002
Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial
G B Lumer, D Roy, M Talajic, et al.
Circulation
|
May 20, 1999
Atrial pacing periablation for prevention of paroxysmal atrial fibrillation
A M Gillis, D G Wyse, S J Connolly, et al.
Journal De Radiologie
|
January 8, 2004
[MRI and in utero ventriculomegaly]
N Girard, A Ozanne, K Chaumoitre, et al.
The New England Journal of Medicine
|
March 30, 2000
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators
D Roy, M Talajic, P Dorian, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 30, 2019
Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC)
Fady M Mikhail, Jaclyn A Biegel, Linda D Cooley, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 111) with videos related to
Sort By:
Page
of 12
Circulation
|
April 1, 1995
Body surface potential distributions during idiopathic ventricular tachycardia
D Klug, A Ferracci, F Molin, et al.
Neurosurgery
|
July 11, 2013
Intertumoral and intratumoral heterogeneity as a barrier for effective treatment of medulloblastoma
Xin Wang, Vijay Ramaswamy, Marc Remke, et al.
Circulation
|
September 1, 1991
Epicardial and endocardial mapping of ventricular tachycardia in patients with myocardial infarction. Is the origin of the tachycardia always subendocardially localized?
W Kaltenbrunner, R Cardinal, M Dubuc, et al.
Acta Neuropathologica Communications
|
January 28, 2014
Polycomb group gene BMI1 controls invasion of medulloblastoma cells and inhibits BMP-regulated cell adhesion
Ashirwad Merve, Adrian M Dubuc, Xinyu Zhang, et al.
Circulation
|
January 11, 2000
Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia
A C Skanes, M Dubuc, G J Klein, et al.
European Heart Journal
|
July 3, 2002
Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial
G B Lumer, D Roy, M Talajic, et al.
Circulation
|
May 20, 1999
Atrial pacing periablation for prevention of paroxysmal atrial fibrillation
A M Gillis, D G Wyse, S J Connolly, et al.
Journal De Radiologie
|
January 8, 2004
[MRI and in utero ventriculomegaly]
N Girard, A Ozanne, K Chaumoitre, et al.
The New England Journal of Medicine
|
March 30, 2000
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators
D Roy, M Talajic, P Dorian, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 30, 2019
Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC)
Fady M Mikhail, Jaclyn A Biegel, Linda D Cooley, et al.
Page
of 12